TB Alliance is governed by a Board of Directors, representing global perspectives and expertise in diverse areas of interest that ensure the success and sustainability of the organization.

Dr. Bruce Carter Chair Retired, Former CEO at Zymogenetics
Mr. Karl Hofmann President and Chief Executive Officer, Population Services International
Nancy Miller-Rich Miller-Rich Associates
Mr. David Norton Formerly, Company Group Chairman, Global Pharmaceuticals, Johnson & Johnson
Dr. Ariel Pablos-Méndez Professor of Medicine, Columbia University Medical Center
Dr. Mario Raviglione Global Health Consultant Former Director, Global TB Programme, World Health Organization
Mr. Paul Sekhri President, CEO and Director, Lycera Corp
Ms. Shalini Sharp Chief Financial Officer and Senior Vice President, Finance, Ultragenyx
Dr. Melvin Spigelman President & Chief Executive Officer, Global Alliance for TB Drug Development
Dr. Debrework Zewdie Vice-Chair Former Senior Advisor, President's Office Special Envoy, World Bank

Our Pipeline

TB Alliance manages the largest pipeline of new TB drugs in history.

View the portfolio